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Abstract
Background: Autism is a common, severe and highly heritable neurodevelopmental disorder in children, affecting up to 100
children per 10,000. The MET gene has been regarded as a promising candidate gene for this disorder because it is located
within a replicated linkage interval, is involved in pathways affecting the development of the cerebral cortex and cerebellum
in ways relevant to autism patients, and has shown significant association signals in previous studies.
Principal Findings: Here, we present new ASD patient and control samples from Heilongjiang, China and use them in a
case-control and family-based replication study of two MET variants. One SNP, rs38845, was successfully replicated in a case-
control association study, but failed to replicate in a family-based study, possibly due to small sample size. The other SNP,
rs1858830, failed to replicate in both case-control and family-based studies.
Conclusions: This is the first attempt to replicate associations in Chinese autism samples, and our result provides evidence
that MET variants may be relevant to autism susceptibility in the Chinese Han population.
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Introduction
Autism is a severe neurodevelopmental disorder of childhood,
diagnosed on the basis of impaired social interaction and
communication, the presence of rigid and stereotyped behaviours,
and disease onset prior to 3 years of age [1]. Autism spectrum
disorder (ASD) is a term that encompasses a broader set of
conditions, including autistic disorder, sometimes called ‘‘classic’’
autism, Asperger syndrome, and pervasive developmental disorder
not otherwise specified (PDD-NOS) [1].
The prevalence of ASD is reported to have increased over time
[2,3]. The current prevalence estimates for ASD range from 90 to
more than 100 per 10,000 in the United States [4] and most other
European countries [5,6,7,8] with a male:female ratio of 3.3:1 to
4.5:1. In China, the prevalence has been reported as ranging from
11.0 to 22.7 per 10,000 in different surveys [9,10,11,12,13], with a
male:female ratio of 1.29:1 to 7.0:1.
Autism is a highly heritable disorder, with a heritability of 70 to
90% [14,15,16,17], and enormous efforts in searching for genetic
susceptibility loci have been going on for decades [17]. The initial
focus was on linkage analysis, and although hundreds of candidate
loci were reported, few have been replicated [18]. Genome-wide
association studies (GWAS) seeking evidence for association with
common SNPs have identified some likely candidate regions, but
these can only account for a small proportion of the heritability
[17]. Rare CNVs have been implicated as possible causal variants
[19], and studies of candidate genes have also achieved some
success.
The MET gene lies within one of the most prominent linkage
intervals, which is also one of the few linkage peaks which have
been replicated in independent studies [18]. It codes for the MET
receptor tyrosine kinase and is activated by the hepatocyte growth
factor/scatter factor (HGF/SF). Although it was initially identified
as a proto-oncogene and plays a role in human cancer
development [20], MET signalling is also involved in many other
processes, such as immune system regulation [21,22], embryo-
genesis and in the peripheral organ development and repair, for
example, gastrointestinal [23,24]. Most relevantly, MET and HGF
are both implicated in neuronal development, especially in the
development of the cerebral cortex and cerebellum, where they
show a highly specific expression pattern. Phenotypic character-
istics caused by impaired MET/HGF signalling such as modified
neuronal migration and disrupted neuronal growth in the cortex,
as well as a decreased proliferation of granule cells causing a
parallel reduction in the size of the cerebellum, have been seen in
the autism patients [25,26,27,28,29,30]. These lines of evidence
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investigation.
Campbell and colleagues [25] first reported an association of a
common promoter variant (G to C, rs1858830) located 20 bp 59 to
the transcription start site of MET with autism. Subsequent studies
have attempted to replicate the association: the same authors
replicated their finding in independent samples in the same report
[25] and then in a third European sample [31]. Jackson et al. [32]
replicated the association of the rs1858830 C allele in two more
samples. Sousa et al. failed to replicate association of rs1858830 in
their sample, but did identify another SNP, rs38845 (within 10 kb
of rs1858830) as being associated with ASD [33]. Thanseem et al.
[34] found association of a third SNP (rs38841; also within 10 kb
of rs1858830) in two samples, one Japanese and the other
American (AGRE).
There has been little investigation of the genetic basis of autism in
the Chinese population, with most studies limited to Western
populations. We have collected 361 Chinese core family samples
consistingofaffected child,motherand father,aswellas 44sporadic
patient samples, together with matched controls, to initiate a
Chinese autism genetic resource for future research. With these
samples, we have begun to test whether the susceptibility genes and
SNPs identified in the European population can be replicated in the
Chinese population, and here report our initial findings on the
association of MET SNPs with autism in a Chinese Han sample.
Results
All 361 trios (both parents and one affected child) and 44
sporadic ASD children, as well as 594 controls (Table 1), were
successfully genotyped for rs38845 using an ABI PRISM
SNaPshot Multiplex Kit (Materials and Methods, Table2). The
genotype frequencies of rs38845 in both ASD cases and controls
were in Hardy-Weinberg equilibrium (x
2 =0.247, p=0.619 and
x
2=0.702, p=0.402, respectively). However, four trio genotype
sets did not conform to a Mendelian transmission pattern and
were excluded from further analysis.
The allele frequencies of rs38845 in the controls were 39.7% A
and 60.3% G, which are almost as same as in the HapMap healthy
Han Chinese samples (40% and 60%, respectively), providing
additional confidence in the genotyping results. There was a
significant difference in the rs38845 allele frequency between ASD
cases (401 cases) and controls (OR=1.24 (1.03–1.49); p=0.019).
If we only considered the autism cases (371 cases), a slightly more
significant difference was found (OR=1.28 (1.06–1.54), p=0.010)
(Table 3). Our case and control male:female ratios were somewhat
different, and even though we do not expect the allele frequency to
differ between males and females for a marker located on an
autosome, we subsampled our controls (568 out of total 594) to
match the case male:female ratio. The association was similar and
still significant (OR=1.26 (1.05–1.52), p=0.015). We also found a
higher frequency of the rs38845 A allele in the cases compared
Table 1. Characteristics of the control and ASD groups.
Number of samples Age (Mean±SD)
sex ratio
(male:female)
Trios with ASD children 361 4.6762.19 310:51
Autism (trio child) 331 4.7262.22 282:49
PDD-NOS (trio child) 30 4.1461.82 28:2
Sporadic ASD children 44 5.3162.53 39:5
Autism 41 5.0362.16 37:4
PDD-NOS 3 9.0663.87 2:1
Controls 594 17.3765.62 489:105
doi:10.1371/journal.pone.0027428.t001
Table 2. Primers and PCR amplification conditions for MET SNPs.
Gene and
SNP Primers for specific fragment Size (bp) Cycles for PCR amplification
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is in the same direction. This result shows that the association of
the rs38845 A allele with both autism only and ASD can be
replicated in Chinese Han samples.
Since we had genotype data from 357 trios, we also carried out
a family-based TDT test. Although we saw slight over-transmis-
sion of the A allele, it was not significant, probably because of the
small sample size (Table 4). To investigate this further, we
estimated the minimum number of trios needed for 80% power to
detect over-transmission, given the Risk Ratio or RR (1.16, 95%
CI: 1.04–1.30) calculated from our case-control analysis. We need
746 or 2,737 trios if we use an RR of 1.2 or 1.1, respectively. The
samples size we have will only provide 80% power to detect the
association with an RR of at least 1.34. Thus the failure to detect
association using the TDT test likely reflects the small sample size.
The SNP rs1858830, which lies in a GC-rich region, failed in
the SNaPshot genotyping assay. However, 343 out of 361 trios,
393 out of 401 cases and 570 out of 594 controls (in all, 96%) were
successfully genotyped using BigDye Sanger sequencing. The
genotype frequencies of rs1858830 in both ASD cases and controls
were in Hardy-Weinberg equilibrium (x
2=1.017, p=0.301 and
x
2=0.264, p=0.608, respectively), but we failed to find any
association in both case-control (Table 3) and TDT analyses
(Table 4). We also carried out the same power analysis for this
SNP, using the RR or OR calculated from the reported allele
frequency differences [25], and the allele frequency observed in
our samples. We need 239 cases and 1,037 trios to get 80% power
to detect such a strong association with such a high frequency
SNP. So our failure to replicate this marker is not because of low
power, at least for the case-control association.
Discussion
Autism is a highly heritable complex disorder and efforts to
identify its genetic basis have been going on for decades. Linkage
studies showed a strong signal in the 7q21–36 region associated
with autism in multiple analyses [18]. The MET gene located in
the region was considered a good candidate both because of the
biological importance of the MET/HGF signalling pathway in
autism aetiology [26,27,28,29,30] and also because of the
successful association of MET variants with autism in previous
studies in European and Japanese populations [25,31,32,33,34].
There have been very limited previous attempts to study the
genetics of autism in China, and few samples have been available
(around 200 cases and 300 controls [35]. We therefore started our
studies of the genetics of autism in China with a replication study
focusing on MET variants. We replicated the association of one
SNP, rs38845, but not that of another, rs1858830, with autism in
our sample collections. Although significant associations for
rs38845 were found in both ASD cases and autism only cases,
the real association may be with autism only, because we observe a
smaller value with this sample. The small size (33 samples) of non-
typical autism cases included in the analysis provides insufficient
power to test for a signal in these cases separately. We considered
the possibility that failed replication of rs1858830 in our sample
collection could be due to a different LD structure in the Chinese
population. We calculated both D’ and r
2 for these two markers
and found that they are not in LD (D’=0.03 and r
2=0.00) which
is actually similar to the European population where D’ is 0.21
[33]. This could suggest the presence of genetic heterogeneity,
with different variants of the MET gene contributing to autism
aetiology in different populations.
In an association study, we always need to consider whether or
not an association we find could be explained by sample
stratification rather than disease status. In our study, four lines
of evidence help to rule out stratification. First, we matched the
control samples very strictly to the cases, and the sample collection
was restricted to one region of China (Heilongjiang Province) and
one ethnic group (Han). Although genetic differences between
Han from the different parts of China have been reported, they
Table 3. Statistical analysis of rs38845 and rs1858830 in the Chinese Han case and control samples.
No. of
subjects Genotype frequencies Allele frequencies p value OR (95% CI)
rs38845 GG GA AA G A
Cases (All ASD) 401 126 (0.314) 189 (0.471) 86 (0.215) 441 (0.550) 361 (0.450) 0.019* 1.242 (1.036–1.489)
Cases (autism only) 369 115 (0.312) 171 (0.463) 83 (0.225) 401 (0.543) 337 (0.457) 0.010** 1.275 (1.059–1.535)
Controls 594 218 (0.367) 280 (0.471) 96 (0.162) 716 (0.603) 472 (0.397)
rs1858830 GG GC CC G C
Cases (All ASD) 393 174 (0.443) 168 (0.427) 51 (0.130) 516 (0.656) 270 (0.344) 0.861 1.017 (0.840–1.231)
Controls 570 240 (0.421) 264 (0.463) 66 (0.116) 744 (0.653) 396 (0.347)
doi:10.1371/journal.pone.0027428.t003
Table 4. Statistical analysis (TDT) of rs38845 and rs1858830 in the Chinese Han trio samples.
rs38845
No. of
subjects G frequency A frequency Transmitted Nontransmitted statistic test
Trios 357 0.564 0.436 181 171 x
2=0.284, P=0.59
rs1858830 G C
Trios 343 0.644 0.356 153 134 x
2=1.258, P=0.262
doi:10.1371/journal.pone.0027428.t004
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Second, the rs38845 allele frequency we found in our control
samples was the same as that in the HapMap samples, which are
also from the northern part of China, providing direct support for
a lack of substantial frequency differences within northern China
at this allele. Third, we also carried out a family-based study (TDT
analysis), which is not influenced by population stratification.
Although we could not confirm the association with this test, this
failure was probably due to the small sample size and the
availability of only simplex families in China because of the one-
child policy; the previous study found a stronger effect of MET
SNPs in families with .1 affected child; nevertheless, we did see
over-transmission of the same allele in the autism-affected
children. Finally, rs1858830 did not show any association. With
all these lines of evidence, we conclude that the association for
rs38845 we have replicated is very likely real.
Here we document what is to our knowledge the first sample
collection devoted to autism genetics in China, which aims to
reach more than 1000 cases and controls within the next two
years. This opens the door to international collaborations for




Study subjects were recruited from the Children Development
and Behavior Research Center (CDBRC), Harbin Medical
University, Heilongjiang Province, China, from Jan. 2007 to
Dec. 2009. All cases were diagnosed independently by more than
two experienced psychiatrists according to the international
Diagnostic and Statistical Manual of Mental Disorders, fourth
edition (DSM-IV) [17] criteria for autism. All the patients were
also assessed using the Childhood Autism Rating Scale (CARS)
[37] and autism behavior checklist (ABC) at the same time [38].
Cases with Rett syndrome, tuberous sclerosis, fragile-X syndrome,
and any other neurological conditions suspected to be associated
with autism were excluded by clinical examination and a
molecular genetic test of the FMR1 gene [39].
361 trios (both parents and one child) with ASD children and 44
sporadic ASD children were collected in the study. General
information on the samples included in this study is summarized in
Table 1. The 405 ASD children were classified as follows: Autistic
Disorder (372 cases), PDD-NOS (33 cases). All the 405 ASD
children were of Chinese Han ethnicity and had a mean age of
4.7462.24 years at the time of diagnosis. 56 were females and 349
were males giving a male:female sex ratio of 6.23:1. A total of 594
Chinese Han controls were also recruited, comprising 489 males
and 105 females with ages from 3 to 24 years for case-control
association analysis. We matched the cases and controls based on
their ancestral geographical origin (three generations from the
same province), life standard (below average, average, above
average) and the parents’ education level. All control children were
examined clinically in the same way and none demonstrated any
features of developmental delay or autistic traits assessed using the
same criteria.
All parents provided written informed consent for themselves
and their children. Ethical permission for this study was obtained
from Ethics Committee of Harbin Medical University [approval
number HAYIWEILUNSHENZi 2007016]. About 5 ml blood
was collected from each patient or control and genomic DNA
extracted from 200 ul using a QIAamp DNA Mini Kit (QIAGEN,
Germany) according to the manufacturer’s instructions.
SNP genotyping
Two SNPs were genotyped: rs1858830 upstream of the MET
gene and rs38845 in the first intron, using an ABI PRISM
SNaPshot Multiplex Kit as described by Xue et al. [40], except
that the initial PCRs to amplify the fragment containing each SNP
were done separately. The primers and PCR conditions are
summarized in Table 2. The PCR products were then mixed in
roughly equal molar amounts, as estimated from their gel band
intensities. The extension PCR products were run on an ABI
PRISM 3100 Genetic Analyzer and data were viewed and
analyzed using GeneScan Analysis Software version 3.5.
The SNP rs1858830 failed in the genotyping assay. The original
PCR products were cleaned up twice using a MultiScreen
PCRm96 Filter Plate (Millipore), then sequenced by BigDye
Sanger sequencing using two pairs of forward primers two or more
times each (downstream of this SNP is a repeat sequence that
prevents sequencing using a reverse primer). The sequencing
primers are listed in Table 2. Variable positions were flagged by
the Mutation Surveyor v. 2.0 software (SoftGenetics) and then
confirmed manually.
Statistical Analysis
Genotypes were coded as GG, GA or AA for rs38845 and GG,
GC, CC for rs1858830, and genotype and allele frequencies were
calculated by direct counting. Data quality control was performed
by checking genotypes for Mendelian consistency within families
and testing Hardy-Weinberg equilibrium in both cases and
controls using a chi-square test. The case-control association
analysis (a chi ˆ2 analysis of contingency table) was performed via
the web-based tool, SISA (http://www.quantitativeskills.com/
sisa/). Both RR and OR were calculated using a multiplicative
risk model. A family-based transmission disequilibrium test (TDT)
[41,42] was performed by comparing the transmitted allele and
the non-transmitted allele from heterozygous parents to the
affected child using Haploview (version 4.2) [43] and a chi-square
test. We used the QUANTO program (http://hydra.usc.edu/
gxe/) for power calculations.
Acknowledgments
We thank all the families and individuals who participated in this study. A
special thanks to all members in the faculty sequencing team of The
Wellcome Trust Sanger Institute for working on improving the protocols
for sequencing rs1858830.
Author Contributions
Conceived and designed the experiments: QA CTS LW Y. Xue.
Performed the experiments: XZ Y. Xu JW HZ XW LW. Analyzed the
data: XZ QA LW Y. Xue. Wrote the paper: XZ CTS Y. Xue.
References
1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition Washington, DC, American Psychiatric
Association.
2. Rutter M (2005) Incidence of autism spectrum disorders: changes over time and
their meaning. Acta Paediatr 94: 2–15.
3. Dodds L, Spencer A, Shea S, Fell D, Armson BA, et al. (2009) Validity of autism
diagnoses using administrative health data. Chronic Dis Can 29: 102–107.
4. (2009) Prevalence of autism spectrum disorders - Autism and Developmental
Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ
58: 1–20.
Replication of MET Association with Autism in Han
PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e274285. (2007) Prevalence of autism spectrum disorders - autism and developmental
disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill
Summ 56: 12–28.
6. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, et al. (2006) Prevalence
of disorders of the autism spectrum in a population cohort of children in South
Thames: the Special Needs and Autism Project (SNAP). Lancet 368: 210–215.
7. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, et al. (2009)
Prevalence of parent-reported diagnosis of autism spectrum disorder among
children in the US, 2007. Pediatrics 124: 1395–1403.
8. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, et al. (2009)
Prevalence of autism-spectrum conditions: UK school-based population study.
Br J Psychiatry 194: 500–509.
9. Wang W, Zai L, Zheng L, Qu X, Feng Q, et al. (2002) An epidemiological
investigation on autistic disorder in Changzhou Chinese Journal of Clinical
Psychological Medicine 12: 48–49.
10. Wong VC, Hui SL (2008) Epidemiological study of autism spectrum disorder in
China. J Child Neurol 23: 67–72.
11. Liu J, Yang X, Jia M, Qu C, Shi J, et al. (2007) Survey on Pervasive
Developmental Disorder in 2-6 Year-old Children in Beijing. Chinese Mental
Health 21: 290–293.
12. Yu C, Xia W, Sun C, Zhou Y, Liu L, et al. (2010) Survey on Autism Spectrum
Disorder in 2-6 years old children in Harbin. Chinese Journal of Child Health
Care 18: 750–753.
13. Zhang X, Ji C, Li J, Sun J (2004) The investigation of autism in children aged 2
to 6 years in Tianjin. Chinese Journal of Reproductive Health 15: 206–208.
14. Folstein S, Rutter M (1977) Infantile autism: a genetic study of 21 twin pairs.
J Child Psychol Psychiatry 18: 297–321.
15. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al. (1995) Autism
as a strongly genetic disorder: evidence from a British twin study. Psychol Med
25: 63–77.
16. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, et al. (1989) A
twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child
Psychol Psychiatry 30: 405–416.
17. Geschwind DH (2009) Advances in autism. Annu Rev Med 60: 367–380.
18. Gupta AR, State MW (2007) Recent advances in the genetics of autism. Biol
Psychiatry 61: 429–437.
19. Kakinuma H, Sato H (2008) Copy-number variations associated with autism
spectrum disorder. Pharmacogenomics 9: 1143–1154.
20. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, et al. (1984)
Molecular cloning of a new transforming gene from a chemically transformed
human cell line. Nature 311: 29–33.
21. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, et al. (2005) A novel
role of hepatocyte growth factor as an immune regulator through suppressing
dendritic cell function. J Immunol 175: 4745–4753.
22. Beilmann M, Vande Woude GF, Dienes HP, Schirmacher P (2000) Hepatocyte
growth factor-stimulated invasiveness of monocytes. Blood 95: 3964–3969.
23. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:
355–365.
24. Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, et al. (2003) Hepatocyte
growth factor facilitates colonic mucosal repair in experimental ulcerative colitis
in rats. J Pharmacol Exp Ther 307: 146–151.
25. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, et al. (2006) A
genetic variant that disrupts MET transcription is associated with autism. Proc
Natl Acad Sci U S A 103: 16834–16839.
26. Elsen GE, Choi LY, Prince VE, Ho RK (2009) The autism susceptibility gene
met regulates zebrafish cerebellar development and facial motor neuron
migration. Dev Biol 335: 78–92.
27. Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P (2009)
Dynamic gene and protein expression patterns of the autism-associated met
receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol 513:
511–531.
28. Campbell DB, D’Oronzio R, Garbett K, Ebert PJ, Mirnics K, et al. (2007)
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann
Neurol 62: 243–250.
29. Judson MC, Eagleson KL, Wang L, Levitt P (2010) Evidence of cell-
nonautonomous changes in dendrite and dendritic spine morphology in the
met-signaling-deficient mouse forebrain. J Comp Neurol 518: 4463–4478.
30. Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P (2011) The
autism risk genes MET and PLAUR differentially impact cortical development.
Autism Res 4: 68–83.
31. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P (2008) Genetic evidence
implicating multiple genes in the MET receptor tyrosine kinase pathway in
autism spectrum disorder. Autism Res 1: 159–168.
32. Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, et al. (2009) Further
evidence that the rs1858830 C variant in the promoter region of the MET gene
is associated with autistic disorder. Autism Res 2: 232–236.
33. Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, et al. (2009) MET and
autism susceptibility: family and case-control studies. Eur J Hum Genet 17:
749–758.
34. Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, et al. (2010)
Further evidence for the role of MET in autism susceptibility. Neurosci Res 68:
137–141.
35. He Y, Xun G, Xia K, Hu Z, Lv L, et al. No significant association between
RELN polymorphism and autism in case-control and family-based association
study in Chinese Han population. Psychiatry Res.
36. Xu S, Yin X, Li S, Jin W, Lou H, et al. (2009) Genomic dissection of population
substructure of Han Chinese and its implication in association studies. Am J Hum
Genet 85: 762–774.
37. Schopler E, Reichler RJ, DeVellis RF, Daly K (1980) Toward objective
classification of childhood autism: Childhood Autism Rating Scale (CARS).
J Autism Dev Disord 10: 91–103.
38. Krug DA, Arick J, Almond P (1980) Behavior checklist for identifying severely
handicapped individuals with high levels of autistic behavior. J Child Psychol
Psychiatry 21: 221–229.
39. Khaniani MS, Kalitsis P, Burgess T, Slater HR (2008) An improved Diagnostic
PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat
Alleles in the Fragile X Gene (FMR1). Mol Cytogenet 1: 5.
40. Xue Y, Zhang X, Huang N, Daly A, Gillson CJ, et al. (2009) Population
differentiation as an indicator of recent positive selection in humans: an
empirical evaluation. Genetics 183: 1065–1077.
41. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage
disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus
(IDDM). Am J Hum Genet 52: 506–516.
42. Spielman RS, Ewens WJ (1996) The TDT and other family-based tests for
linkage disequilibrium and association. Am J Hum Genet 59: 983–989.
43. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and
visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
Replication of MET Association with Autism in Han
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27428